This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is It Advisable to Add Centene (CNC) to Your Portfolio?
by Zacks Equity Research
Centene (CNC) looks a solid bet, driven by its underlying strength and earnings growth prospects.
UnitedHealth Keeps '17 Guidance & Issues '18 View, Stock Up
by Zacks Equity Research
UnitedHealth's (UNH) strong guidance for 2018 reflects its robust fundamentals amid a volatile regulatory backdrop.
Ensign Group Rides on Inorganic Growth, High Expenses Hurt
by Zacks Equity Research
Although Ensigh Group's (ENSG) revenue growth has been positively impacted by its solid inorganic strategies, it suffers from rising level of expenses that weigh on the margins.
WellCare Health's (WCG) Top Line Grows on Inorganic Efforts
by Zacks Equity Research
WellCare Health (WCG) benefits from several organic and inorganic strategies. Moreover, a solid financial background enhances shareholder's value.
Can Obamacare Brave the Tax Cuts Challenge? 4 Hospital Picks
by Swarup Gupta
The passage of the Senate Republicans draft is far from assured at this point.
Anthem's (ANTM) Notes Receive Rating Action From A.M Best
by Zacks Equity Research
Anthem (ANTM) receives favorable ratings from the rating agencies on the back of operational excellence and financial flexibility
Will Health Insurers Have to Rework Under ACHA?
by Zacks Equity Research
The overall expectation is that the new regulatory framework will provide for a relatively lighter regulatory touch and will be friendlier to the industry. That said, the expected change would have some negative effects on the industry as well.
WellCare Health Plans Prices Senior Notes Worth $1.2 Billion
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) issued 5.25% $1.2 billion senior notes with maturity scheduled on Apr 1, 2025.
Humana (HUM) Includes Methodist Healthcare in its Network
by Zacks Equity Research
Humana Inc. (HUM) recently entered into an agreement with Methodist Healthcare to provide better service to its patients.
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
Will Joint (JYNT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Joint Corp. (JYNT)
Will Trump Era Mean Disaster for Health Insurers?
by Mark Vickery
Health insurance companies provided a major overhaul of their business plans to comply with Obamacare, and now they look to be put on a new road forward.